Deal sells 1,303,780 shares at $7.67 each to investor Aventis Holdings
By Devika Patel
Knoxville, Tenn., Feb. 5 - Regulus Therapeutics Inc. settled a $10 million private placement of stock with Aventis Holdings Inc. on Feb. 4, according to an 8-K filed Wednesday with the Securities and Exchange Commission.
The company sold 1,303,780 common shares at $7.67 per share, which is a 9.98% discount to the Feb. 3 closing share price of $8.52 and is also the daily volume-weighted average price of the stock for the 30 trading days preceding the purchase agreement, the filing said.
The manufacturer of earth-friendly products is based in Wilsonville, Ore.
| Issuer: | Regulus Therapeutics Inc.
|
| Issue: | Common stock
|
| Amount: | $10 million
|
| Shares: | 1,303,780
|
| Price: | $7.67
|
| Warrants: | No
|
| Investor: | Aventis Holdings Inc.
|
| Settlement date: | Feb. 4
|
| Stock exchange: | Nasdaq: RGLS
|
| Stock price: | $8.52 at close Feb. 3
|
| Market capitalization: | $355.94 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
